Dr. Sara Assaf, MD

Dr. Assaf practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Assaf's NPI, 1396150397, was assigned on June 27, 2014. Dr. Assaf graduated from Saint George's University School of Medicine in 2025. Dr. Assaf holds New Mexico license MD2020-0231.

Dr. Assaf's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Assaf's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. Dr. Assaf is also affiliated with Harris Health Ben Taub Hospital. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Assaf to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Assaf practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Assaf's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Assaf's licenses on file in 2 states: New Mexico and Missouri.

Dmand AI lists acute diabetes, acute sinusitis, asthma, chronic kidney disease, chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure and heart failure among the conditions Dr. Assaf treats.

CMS data shows 295 Medicare services from Dr. Assaf across 7 procedure codes in 2024, for 189 Medicare patients. Medicare paid $30,773 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 189 Medicare patients who saw Dr. Assaf in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Assaf's median patient age at 71, with 62% women.

In 2024, Dr. Assaf wrote 692 Medicare Part D claims for 128 patients. 25% of them were for generic drugs. CMS names the drug for 622 of them, across 17 drugs with 11 or more claims each, at $244,913 in total drug cost. In 2023, CMS named 732 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Assaf for performance year 2024, reported as part of a group. Dr. Assaf accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Assaf, published from 2023 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Asthma, Anti-Asthmatic Agents and COVID-19. Dr. Assaf has published most often in Respir Med. Dr. Assaf's most frequent co-authors are Nicola A. Hanania, MD, Briana E. Disilvio, MD and Anam Javed, MD.

CMS Open Payments shows 3 general payments to Dr. Assaf from 2 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $216.

Dr. Assaf graduated from Saint George's University School of Medicine in 2025.

Dr. Assaf is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.